SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008495
Filing Date
2022-05-09
Accepted
2022-05-09 16:12:04
Documents
60
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crsp-20220331.htm   iXBRL 10-Q 1959345
2 EX-31.1 crsp-ex31_1.htm EX-31.1 14204
3 EX-31.2 crsp-ex31_2.htm EX-31.2 14210
4 EX-32.1 crsp-ex32_1.htm EX-32.1 13251
  Complete submission text file 0000950170-22-008495.txt   7817579

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crsp-20220331.xsd EX-101.SCH 42692
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crsp-20220331_lab.xml EX-101.LAB 381272
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crsp-20220331_def.xml EX-101.DEF 158262
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crsp-20220331_cal.xml EX-101.CAL 46158
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crsp-20220331_pre.xml EX-101.PRE 268776
54 EXTRACTED XBRL INSTANCE DOCUMENT crsp-20220331_htm.xml XML 1727706
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37923 | Film No.: 22905060
SIC: 2836 Biological Products, (No Diagnostic Substances)